Detection of circulating epithelial cells after surgery for benign breast disease.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 10837087)

Published in Mol Diagn on March 01, 2000

Authors

D Crisan1, D S Ruark, D A Decker, A M Drevon, R G Dicarlo

Author Affiliations

1: Department of Clinical Pathology, William Beaumont Hospital, Royal Oak, MI 48073-6769, USA. dcrisan@beaumont.edu

Articles by these authors

Inhibition of PCR by aqueous and vitreous fluids. J Clin Microbiol (1995) 2.35

Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol (1995) 2.08

Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck. Cancer (1983) 1.39

Specimen stability for DNA-based diagnostic testing. Diagn Mol Pathol (1996) 1.26

Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysis. JAMA (1979) 0.93

The significance of a cytologically negative pleural effusion in bronchogenic carcinoma. Chest (1978) 0.88

Hypercalcemia in head and neck carcinoma. Incidence and prognosis. Cancer (1983) 0.87

The EEG in intrinsic supratentorial brain tumors: a comparative evaluation. Electroencephalogr Clin Neurophysiol (1972) 0.87

Respiratory arrest in myasthenia gravis with colistimethate therapy. Arch Neurol (1971) 0.86

Chemotherapy for nasopharyngeal carcinoma. A ten-year experience. Cancer (1983) 0.85

Physician order entry. MD Comput (1994) 0.84

Cytometrically coherent transfer of receptor proteins on microporous membranes. Biotechniques (1991) 0.84

Brain metastases in patients with renal cell carcinoma: prognosis and treatment. J Clin Oncol (1984) 0.80

Impact of clinical, pathologic, and treatment-related factors on outcome in patients with locally advanced breast cancer treated with multimodality therapy. Am J Clin Oncol (1999) 0.79

High-dose methotrexate with a safe rescue program. Oncology (1981) 0.78

High-dose ketoconazole therapy in patients with metastatic prostate cancer. Am J Clin Oncol (1986) 0.77

Computerized bone scan. A potentially useful technique to measure response in prostatic carcinoma. Cancer (1984) 0.77

Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report. J Neurooncol (1985) 0.77

The natural history of hyalinization of ACTH-MSH cells in man. Arch Pathol (1971) 0.77

L-Dopa therapy in Parkinson's disease (a year's experience with 20 patients). J Iowa Med Soc (1970) 0.75

Local tissue reaction to intravenous fluorouracil and leucovorin. DICP (1991) 0.75

Phase II evaluation of aclacinomycin-A (NSC-208734) in adenocarcinoma of the kidney. Am J Clin Oncol (1984) 0.75

Phase II evaluation of aclacinomycin-A in advanced ovarian carcinoma. Invest New Drugs (1987) 0.75

PCNU in advanced adenocarcinoma of the ovary: a phase II study. Cancer Treat Rep (1983) 0.75

A computer in the office: yesterday, today and tomorrow. Nebr Med J (1987) 0.75

Phase II clinical evaluation of AZQ in renal cell carcinoma. Am J Clin Oncol (1986) 0.75

Phase II clinical evaluation of AZQ in adenocarcinoma of the lung. Am J Clin Oncol (1984) 0.75

Preliminary study of a combination of adriamycin, bleomycin, and diamminedichloroplatinum in advanced cancer. Med Pediatr Oncol (1978) 0.75

Textual data versus encoded data. MD Comput (1989) 0.75

An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer. Oncology (1980) 0.75

Evaluation of gallium nitrate in metastatic or locally recurrent squamous cell carcinoma of the head and neck: a Southwest Oncology Group study. Cancer Treat Rep (1984) 0.75

M-AMSA in disseminated prostatic carcinoma: a phase II study. Cancer Treat Rep (1982) 0.75

Case report of non-Hodgkin's lymphoma involving the lacrimal glands demonstrated by computed tomography. Cancer (1981) 0.75

Scalp artery to cerebral cortical artery anastomosis in the early treatment of stroke. Nebr Med J (1979) 0.75

Artificial intelligence and medical decision making. Nebr Med J (1987) 0.75